Pricing Log in Create free account

Krystal Biotech, Inc. (KRYS) vs TG Therapeutics, Inc. (TGTX)

Krystal Biotech, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and TG Therapeutics, Inc. are of similar size ($8.9B and $8.9B). TG Therapeutics, Inc. trades at the lower P/E: 19.1× against 39.2×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 26.0%. TG Therapeutics, Inc. has the higher net margin (55.2% vs 47.9%) and the lower return on invested capital (10.7% vs 27.2%). Across the 20 metrics below, Krystal Biotech, Inc. leads on 11 and TG Therapeutics, Inc. on 9.

Valuation

Metric KRYS TGTX Biotechnology median
P/E 39.21 19.11 10.26
P/S 18.92 10.30 9.18
P/B 6.20 13.64 2.05
Price to free cash flow 28.68 473.79 24.81
EV/EBITDA 34.07 62.00 0.65
EV/Sales 16.98 10.54 8.98
Earnings yield 2.55% 5.23% (34.89%)
Free cash flow yield 3.49% 0.21% (24.52%)

Profitability

Metric KRYS TGTX Biotechnology median
Gross margin 94.27% 82.37% 65.16%
Operating margin 48.41% 17.05% 0.00%
Net margin 47.91% 55.22% 0.00%
Free cash flow margin 65.97% 2.17% 0.00%
Return on equity 17.50% 100.28% (50.12%)
Return on assets 15.93% 37.70% (45.60%)
Return on invested capital 27.15% 10.69% 0.00%

Growth

Metric KRYS TGTX Biotechnology median
Revenue growth (TTM) 25.96% 76.08% 6.26%
EPS growth (last fiscal year) 128.00% 1,746.67% 29.88%
Revenue growth, 5-year CAGR — 426.73% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRYS TGTX Biotechnology median
Debt to equity 0.00 1.23 0.00
Current ratio 7.89 4.27 4.89
Net debt to EBITDA (4.93) 0.86 1.01

Dividend

Metric KRYS TGTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KRYS TGTX Biotechnology median
Market cap 8.90b 8.87b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack